Dr. Ron Aviles explains available procedures and recovery time for those with heart and vascular conditions. Sponsored by Overlake Medical Center and Clinics.
Regor Pharmaceuticals Inc. has divulged phosphatidylinositol 3-kinase (PI3K) inhibitors reported to be useful for the treatment of cancer, congenital lipomatous overgrowth, vascular malformations, ...
The incidence of gastroschisis is approximately 1.4 per 10,000 pregnancies and is rarely associated with other congenital anomalies. To provide appropriate care for these infants, the newborn ...
CVI Pharmaceuticals Ltd. has identified thyroid hormone receptor (THR)-β agonists reported to be useful for the treatment of atherosclerosis, hypercholesterolemia, hyperlipidemia, hepatic steatosis, ...
Active surveillance of CRS must be integrated with other mother-and-child preventive measures: neonatal hearing screening and surveillance of congenital malformations and neurodevelopment disorders.